Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia

Neurosurgical Review

Volumn 23, Issue 3, 2000, Pages 145-150

  Korenkov, Alexei I ^a   Pahnke, Jens ^a   Frei, Karl ^b   Warzok, Rolf ^a   Schroeder, Henry W S ^a   Frick, Rosemarie ^b   Muljana, Lydia ^b   Piek, Jurgen ^a   Yonekawa, Yasuhiro ^b   Gaab, Michael R ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cerebroprotection; Focal cerebral ischemia; Mannitol; Nimodipine; Programmed neuronal death

Indexed keywords

MANNITOL; NIMODIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033780304     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011946     Document Type: Article

References (73)

1. Effects of mannitol on cerebral blood flow, blood pressure, blood viscosity, hematocrit, sodium, and potassium
2. Apoptosis. The role of the endonuclease
3. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia
4. Thresholds in cerebral ischemia - The ischemic penumbra
5. Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists
6. Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms
7. Oxidative stress as a mediator of apoptosis
8. Redox regulation of programmed cell death in lymphocytes
9. Apoptosis and necrosis after reversible focal ischemia: An in situ DNA fragmentation analysis
10. Apoptosis in focal cerebral ischemia
11. Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo
12. Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey
13. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: Evidence against programmed cell death
14. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons
15. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption
16. Oxygen radical production and thiol depletion are required for Ca(2+)-mediated endogenous endonuclease activation in apoptotic thymocytes
17. Brain edema, autoregulation, and calcium antagonism. An experimental study with nimodipine
18. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
19. Ischemic penumbra: The therapeutic window
20. Mannitol, intracranial pressure, and vasogenic edema
21. The effect of mannitol on cerebral blood flow
22. Thresholds of focal cerebral ischemia in awake monkeys
23. Calcium dependence of glucocorticoid-induced lymphocytolysis
24. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
25. Anatomical methods in cell death
26. Effect of mannitol on focal cerebral ischemia evaluated by magnetic resonance imaging
27. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolismus in rats in which recirculation can be introduced in the ischemic area
28. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat
29. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats
30. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat
31. Programmed cell death in cerebral ischemia
32. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion
33. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
34. The effect of mannitol on experimental cerebral ischemia, revisited
35. Apoptosis, oncosis, and necrosis. An overview of cell death
36. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells
37. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells
38. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct
39. Treatment of traumatic brain injury with moderate hypothermia
40. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells
41. Effect of S-emopamil, nimodipine, and mild hypothermia on hippocampal glutamate concentrations after repeated cerebral ischemia in rabbits
42. Calcium and cyclosporin A in the regulation of apoptosis
43. Signal transduction pathways in apoptosis
44. The role of calcium in the regulation of apoptosis
45. Treatment of experimental focal cerebral ischemia with mannitol. Assessment by intracellular brain pH, cortical blood flow, and electroencephalography
46. Correlation between cerebral blood flow and histologic changes in a new rat model of middle Cerebral artery occlusion
47. Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis
48. Mild hypothermia, hypertension, and mannitol are protective against infarction during experimental intracranial temporary vessel occlusion
49. Multipledose mannitol reduces brain water content in a rat model of cortical infarction
50. Neuronal protective effects of calcium antagonists in cerebral ischemia
51. Pro-oxidants and mitochondrial Ca2+: Their relationship to apoptosis and oncogenesis
52. The effect of mannitol and nimodipine treatment in a rat model of temporary focal ischemia
53. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T cell line in serum-free medium
54. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis
55. Lipid hydroperoxide-induced apoptosis: Lack of inhibition by Bcl-2 over-expression
56. Effects of retrograde perfusion of the brain with combined drug therapy after focal ischemia in rat brain
57. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology
58. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment
59. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis
60. Calpain activation in apoptosis
61. Recirculation in the acute period of cerebral infarction: Brain swelling and its suppression using mannitol
62. Protective effect of phenytoin and its enhanced action by combined administration with mannitol and vitamin E in cerebral ischemia
63. Effects of nimodipine in experimental permanent focal cerebral ischemia
64. Apoptosis: Cell death in tissue regulation
65. Cell death: The significance of apoptosis
66. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
67. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
68. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
69. Neuroprotection by the novel calcium antagonist PCA50938, nimodipine, and flunarizine in gerbil global brain ischemia
70. The oxidative inactivation of mitochondrial electron transport chain components and ATPase
71. Cellular and molecular neurosurgery: Pathways from concept to reality. Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system
72. Neuroprotective properties of calcium channel blockers